| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT05792462 Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders |
Phase changed: Phase 1/2 -> Phase 1 |
| 2026-08-04 | NCT05792462 Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders |
Enrollment closed, study ongoing |
| 2026-08-04 | NCT05792462 Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders |
Primary endpoint(s) modified |
| 2026-08-04 | NCT05792462 Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders |
date change Primary completion pushed: 2025-12-30 -> 2027-03-01 |
| 2026-08-04 | NCT05792462 Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders |
date change Completion pushed: 2025-12-30 -> 2027-03-01 |
| 2026-08-02 | NCT06497374 FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack |
overall status: Not Yet Recruiting → Unknown |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-12 | NCT07760740 The Effect of Intraoperative Infusion of Esketamine on Cholestatic Pruritus in Patients… | Not Yet Recruiting | |
| 2026-08-11 | NCT07758062 Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07162090 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis… | Sarcopenia | Not Yet Recruiting |
| NCT07018375 | The Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative… | Chronic Postsurgical Pain | Enrolling by Invitation |
| Phase 3 | |||
| NCT07420296 | Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder | Neuromyelitis Optica Spectrum Disorders (NMOSD) | Recruiting |
| NCT07132398 | Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD | Neuromyelitis Optica (NMO) | Not Yet Recruiting |
| NCT07497542 | Normal Saline Infusion After Intravenous Thrombolysis in Stroke | Brain Infarction | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT05403138 | Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive… | Neuromyelitis Optica | Active, Not Recruiting |
| NCT06452537 | Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein… | Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease | Active, Not Recruiting |
| Phase 2 | |||
| NCT06327451 | Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the… | Glioblastoma, IDH-wildtype | Recruiting |
| NCT05369351 | Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage | Intracerebral Haemorrhage | Recruiting |
| NCT07184840 | Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder | Neuromyelitis Optica Spectrum Disorder Attack | Active, Not Recruiting |
| NCT07758062 | Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma | Glioblastoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06548802 | Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury | Pulmonary Injury After Intracerebral Hemorrhage | Recruiting |
| NCT06911710 | The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic… | Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL) | Recruiting |
| NCT07022197 | Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases | Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Recruiting |
| NCT06561009 | Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum… | Neuromyelitis Optica Spectrum Disorder | Not Yet Recruiting |
| Phase 1 | |||
| NCT05792462 | Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders | NMO Spectrum Disorder | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT07498439 | TILs Therapy for Multiple Primary Early-Stage NSCLC | Primary Early-stage Non-small Cell Lung Cancer | Not Yet Recruiting |
| NCT07498595 | TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC | EGFR-TKI-resistant Non-Small Cell Lung Cancer | Not Yet Recruiting |
| Not specified | |||
| NCT06108830 | Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in… | Sleep Disturbance | Recruiting |
| NCT06746610 | Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic… | Monogenic Diabetes | Recruiting |
| NCT07492004 | China Monogenic Diabetes Registry | Neonatal Diabetes | Recruiting |
| NCT06228781 | Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis | Multiple Sclerosis | Not Yet Recruiting |
| NCT07560722 | The Effect of a Single Intravenous Injection of Esketamine During Cesarean Section on… | Intrahepatic Cholestasis of Pregnancy | Not Yet Recruiting |
| NCT07597486 | The Effect of Intraoperative Esketamine Infusion on Pruritus in Elderly Surgical Patients | Senile Pruritus | Not Yet Recruiting |
| NCT07760740 | The Effect of Intraoperative Infusion of Esketamine on Cholestatic Pruritus in Patients… | Cholestatic Pruritus | Not Yet Recruiting |